IL119710A - Process for producing N-(3-(3-cyano- pyrazolo (1,5-a) pyrimidin-7- YL) phenyl)-N- ethyl-acetamide - Google Patents

Process for producing N-(3-(3-cyano- pyrazolo (1,5-a) pyrimidin-7- YL) phenyl)-N- ethyl-acetamide

Info

Publication number
IL119710A
IL119710A IL11971096A IL11971096A IL119710A IL 119710 A IL119710 A IL 119710A IL 11971096 A IL11971096 A IL 11971096A IL 11971096 A IL11971096 A IL 11971096A IL 119710 A IL119710 A IL 119710A
Authority
IL
Israel
Prior art keywords
pyrazolo
pyrimidin
acetamide
cyano
phenyl
Prior art date
Application number
IL11971096A
Other languages
English (en)
Other versions
IL119710A0 (en
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of IL119710A0 publication Critical patent/IL119710A0/xx
Publication of IL119710A publication Critical patent/IL119710A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IL11971096A 1995-12-01 1996-11-28 Process for producing N-(3-(3-cyano- pyrazolo (1,5-a) pyrimidin-7- YL) phenyl)-N- ethyl-acetamide IL119710A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US785995P 1995-12-01 1995-12-01

Publications (2)

Publication Number Publication Date
IL119710A0 IL119710A0 (en) 1997-02-18
IL119710A true IL119710A (en) 1999-11-30

Family

ID=21728482

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11971096A IL119710A (en) 1995-12-01 1996-11-28 Process for producing N-(3-(3-cyano- pyrazolo (1,5-a) pyrimidin-7- YL) phenyl)-N- ethyl-acetamide

Country Status (25)

Country Link
US (1) US5714607A (de)
EP (1) EP0776898B1 (de)
JP (1) JP4112032B2 (de)
KR (1) KR100439282B1 (de)
CN (1) CN1057525C (de)
AR (1) AR004822A1 (de)
AT (1) ATE227290T1 (de)
AU (1) AU718310B2 (de)
BR (1) BR9605760A (de)
CA (1) CA2191647C (de)
CY (1) CY2440B1 (de)
CZ (1) CZ292253B6 (de)
DE (1) DE69624657T2 (de)
DK (1) DK0776898T3 (de)
ES (1) ES2184844T3 (de)
HU (1) HU226398B1 (de)
IL (1) IL119710A (de)
MX (1) MX9605974A (de)
NO (1) NO307181B1 (de)
NZ (1) NZ299848A (de)
PT (1) PT776898E (de)
RU (1) RU2178415C2 (de)
SK (1) SK281807B6 (de)
TW (1) TW382629B (de)
ZA (1) ZA9610008B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399621B1 (en) 1999-08-10 2002-06-04 American Cyanamid Company N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
US6485746B1 (en) 2000-08-25 2002-11-26 Neurocrine Biosciences, Inc. Controlled-release sedative-hypnotic compositions and methods related thereto
US20030091632A1 (en) * 1999-08-26 2003-05-15 Neurocrine Biosciences, Inc. Controlled-release sedative-hypnotic compositions and methods related thereto
US6384221B1 (en) * 1999-09-02 2002-05-07 Neurocrine Biosciences, Inc. Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
AU2001283119B2 (en) * 2000-08-03 2007-11-15 Wyeth Polymorphs of zaleplon and methods for the preparation thereof
EP1526136A1 (de) * 2000-08-03 2005-04-27 Wyeth Polymorphe Formen von Zaleplon und Verfahren zu ihrer Herstellung
AR029780A1 (es) 2000-12-13 2003-07-16 Gador Sa Procedimiento mejorado para la obtencion de n-[3(3-ciano-pirazolo[1,5-a]pirimidin-7-il)fenil]-n-etil-acetamida
PL372942A1 (en) * 2001-06-12 2005-08-08 Biogal Gyogyszergyar Rt Process for the production of n-[3-(3-cyanopyrazolo[1,5-a] pyrimidin-7-yl)phenyl]-n-ethylacetamide (zaleplon)
US20050032818A1 (en) * 2001-06-12 2005-02-10 Entire Interest N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-5-yl)phenyl]-N-ethylacetamide and crystalline forms of zaleplon
IL160076A0 (en) * 2001-08-01 2004-06-20 Biogal Gyogyszergyar Process for purifying n-[3-(3-cyanopyrazolo{1,5-a} pyrimidin-7-yl) phenyl]-n-ethylacetamide (zaleplon) and crystalline forms of zaleplon accessible with the process
EP1476446B1 (de) * 2002-02-14 2007-08-01 Cilag AG Verfahren zur herstellung von n-ethyl-n-(3-(3-cyanopyrazolo-(1,5-a)-pyrimidin-7-yl)phenyl)-acetamid
WO2003068238A1 (en) * 2002-02-15 2003-08-21 Biogal Gyogyszergyar Rt. Powder composition comprising zaleplon of defined particle size distribution and pharmaceutical products made therefrom
PL207322B1 (pl) * 2002-05-14 2010-11-30 Adamed Społka Z Ograniczoną Odpowiedzialnością Sposób wytwarzania zaleplonu
KR101248123B1 (ko) 2003-09-04 2013-03-27 씨아이피엘에이 엘티디. 잘레플론의 합성
US20050176680A1 (en) 2003-12-11 2005-08-11 Sepracor, Inc. Combination of sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
DE602004025747D1 (de) * 2004-01-14 2010-04-08 Mallinckrodt Inc Zweiphasiges verfahren zur synthese ausgewählter pyrazolopyrimidine
HUP0400325A3 (en) 2004-02-02 2005-11-28 Richter Gedeon Vegyeszet Pure n-[3-(-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethyl-acetamide, process for its preparation and intermediates
WO2005079851A2 (en) 2004-02-18 2005-09-01 Sepracor, Inc. Dopamine-agonist combination therapy with sedatives for improving sleep quality
WO2006070244A2 (en) * 2004-11-22 2006-07-06 Bakulesh Mafatlal Khamar A process for the preparation of zaleplon
TW200815428A (en) * 2006-08-15 2008-04-01 Wyeth Corp Oxazolidone derivatives as PR modulators
WO2008021337A1 (en) 2006-08-15 2008-02-21 Wyeth Oxazinan-2-one derivatives useful as pr modulators
US7649007B2 (en) * 2006-08-15 2010-01-19 Wyeth Llc Oxazolidine derivatives as PR modulators
WO2008021309A1 (en) * 2006-08-15 2008-02-21 Wyeth Imidazolidin-2-one derivatives useful as pr modulators
WO2008068600A2 (en) * 2006-12-06 2008-06-12 Orchid Chemicals & Pharmaceuticals Limited An improved process for the preparation of zaleplo
CZ2008468A3 (cs) 2008-07-31 2009-11-18 Farmak, A. S. Zpusob prípravy N-(1-benzo[b]thien-2-ylethyl)-N-hydroxymocoviny
CN102816163A (zh) * 2012-08-20 2012-12-12 四川禾邦阳光制药股份有限公司 扎来普隆的新晶型及制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3907799A (en) * 1971-08-16 1975-09-23 Icn Pharmaceuticals Xanthine oxidase inhibitors
US4281000A (en) * 1979-07-09 1981-07-28 American Cyanamid Company Substituted pyrazolo (1,5-a)pyrimidines and their use as anxiolytic agents
NZ208554A (en) * 1983-06-23 1987-06-30 American Cyanamid Co (aryl and heteroaryl)-(7-(aryl and heteroaryl)-pyrazolo (1,5-a) pyrimidin-3-yl)-methanone derivatives and pharmaceutical compositions
US4521422A (en) * 1983-06-23 1985-06-04 American Cyanamid Company Aryl and heteroaryl[7-(aryl and heteroaryl)pyrazolo[1,5-a]pyrimidin-3-yl]methanones
US4626538A (en) * 1983-06-23 1986-12-02 American Cyanamid Company [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines
JPS62270584A (ja) * 1986-04-28 1987-11-24 Yoshitomi Pharmaceut Ind Ltd ４，７−ジヒドロピラゾロ〔１，５−ａ〕ピリミジン誘導体
RO108347B1 (ro) * 1989-10-30 1994-04-28 Bellon Labor Sa Roger DERIVATI DE BENZO-(b)-NAFTIRIDIN-1,8 SI PROCEDEU DE PREPARARE A ACESTORA
US5356897A (en) * 1991-09-09 1994-10-18 Fujisawa Pharmaceutical Co., Ltd. 3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines
GB9321162D0 (en) * 1993-10-13 1993-12-01 Boots Co Plc Therapeutic agents

Also Published As

Publication number Publication date
CN1163893A (zh) 1997-11-05
US5714607A (en) 1998-02-03
BR9605760A (pt) 1998-08-25
AU7409196A (en) 1997-06-05
PT776898E (pt) 2003-02-28
IL119710A0 (en) 1997-02-18
DE69624657D1 (de) 2002-12-12
MX9605974A (es) 1998-04-30
HUP9603275A3 (en) 1997-10-28
NO965084L (no) 1997-06-02
EP0776898B1 (de) 2002-11-06
DK0776898T3 (da) 2003-02-24
CZ292253B6 (cs) 2003-08-13
SK281807B6 (sk) 2001-08-06
AR004822A1 (es) 1999-03-10
DE69624657T2 (de) 2003-08-21
HU9603275D0 (en) 1997-01-28
CN1057525C (zh) 2000-10-18
NZ299848A (en) 1998-09-24
EP0776898A1 (de) 1997-06-04
ATE227290T1 (de) 2002-11-15
HUP9603275A2 (en) 1997-08-28
NO307181B1 (no) 2000-02-21
CZ350596A3 (en) 1997-09-17
KR970042543A (ko) 1997-07-24
ES2184844T3 (es) 2003-04-16
ZA9610008B (en) 1998-08-28
KR100439282B1 (ko) 2004-08-31
JP4112032B2 (ja) 2008-07-02
JPH09216885A (ja) 1997-08-19
AU718310B2 (en) 2000-04-13
NO965084D0 (no) 1996-11-28
RU2178415C2 (ru) 2002-01-20
TW382629B (en) 2000-02-21
HU226398B1 (en) 2008-11-28
SK153696A3 (en) 1997-11-05
CA2191647A1 (en) 1997-06-02
CA2191647C (en) 2005-01-25
CY2440B1 (en) 2004-11-12

Similar Documents

Publication Publication Date Title
IL119710A (en) Process for producing N-(3-(3-cyano- pyrazolo (1,5-a) pyrimidin-7- YL) phenyl)-N- ethyl-acetamide
GB2311522B (en) Process for producing perfluorocarbon
SG70081A1 (en) Process for producing diamines
NZ313165A (en) Process for producing n-substituted 3-hydroxypyrazoles
AU7495496A (en) Process for preparing 1,3-propanediol
EP0857790A4 (de) Verfahren zur herstellung optisch aktiver aminoverbindungen
EP0765890A3 (de) Verfahren zur Herstellung eines Kautschukzusammensetzung
IL117406A0 (en) Novel process for preparing 2,3-dihydro-benzofuranol derivatives
HUP9602960A2 (en) Process for producing alkylcarbazates
EP0742221A3 (de) Verfahren zur Herstellung von Trimethylaluminium
HUP9802054A3 (en) Process for producing 4,4,5,5,5-pentafluor-1-pentanol
EP0751111A3 (de) Verfahren zur Herstellung von 2,2-Dialkylaryliden-cycloalkanonen
HUP9802105A3 (en) Process for producing 2,3,4,5-tetrafluorbenzene derivatives
HUP9602988A3 (en) Process for producing 2-chloracrylnitril
GB9614359D0 (en) Process for producing c2-substituted optically active 2,3-dihydro-4h-pyran-4-one
HU9600316D0 (en) Process for producing n-(o-alkyl-phenyl)-imides
HUP9701064A2 (hu) Eljárás N-(2-karboxi-5-klór-fenil)-glicin előállítására
GR3030254T3 (en) Process for preparing substituted aminotriazolinones
EP0751112A3 (de) Verfahren zur Herstellung von Arylidensubstituierten Alkylcycloalkanonen
HU9702176D0 (en) New process for producing lisinoprile
HU9800614D0 (en) Process for producing 1,3-dioxane compounds
AU5898696A (en) Process for producing aromatic nitriles
IL120556A (en) Process for the preparation of 3,3,5-trichloroglutarimide
HU9701476D0 (en) Process for producing dexfenfluramine hydrochloride
HU9503733D0 (en) Process for producing veratrumaldehyde

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees